These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 6677532)

  • 21. [Economical production of rabies vaccine on cell cultures].
    Lalosević D; Lazarević-Ivanc L; Stankov S
    Med Pregl; 1997; 50(11-12):565-8. PubMed ID: 9471524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunochemical characterization of rabies virus: determination of precipitable antigens].
    Zapata MT; Márquez A; Yantorno C; Riera MC; Scrimini C
    Rev Asoc Argent Microbiol; 1978; 10(2):70-7. PubMed ID: 116328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural and immunogenic characteristics of rabies immunosomes.
    Perrin P; Sureau P; Thibodeau L
    Dev Biol Stand; 1985; 60():483-91. PubMed ID: 4043539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and replication of rabies virus in C6 rat glioma cells (clone CCL-107).
    Bordignon J; Piza AT; Alvarez-Silva M; Caporale GM; Carrieri ML; Kotait I; Zanetti CR
    Biologicals; 2001 Jun; 29(2):67-73. PubMed ID: 11580211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immune response of mice to replication-defective recombinant adenovirus containing glycoprotein gene of rabies virus 3aG strain].
    Li W; Zhang Y; Wang S
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Mar; 15(1):61-5. PubMed ID: 12526306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A DNA vaccine that encodes rabies virus glycoprotein lacking transmembrane domain enhances antibody response but not protection.
    Gupta PK; Sharma S; Walunj SS; Patil AA; Rai A; Saini M
    Acta Virol; 2006; 50(2):87-92. PubMed ID: 16808325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cultivation of the rabies virus in the continuous kidney cell line 4647 from the green marmoset].
    Aksenova TA; Mironova LL; Grachev VP; Selimov MA; Preobrazhenskaia NK
    Vopr Virusol; 1985; 30(2):180-2. PubMed ID: 2408382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production and control of rabies vaccines made on diploid cells.
    Wiktor TJ
    Dev Biol Stand; 1976 Dec 13-15; 37():265-6. PubMed ID: 1031688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Biological characteristics of the adapted rabies virus 3aG-V in Vero cell].
    Shi XS
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec; 18(4):348-50. PubMed ID: 15650786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vero-cell rabies vaccine produced using serum-free medium.
    Frazatti-Gallina NM; Mourão-Fuches RM; Paoli RL; Silva ML; Miyaki C; Valentini EJ; Raw I; Higashi HG
    Vaccine; 2004 Dec; 23(4):511-7. PubMed ID: 15530700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.
    Rourou S; van der Ark A; van der Velden T; Kallel H
    Vaccine; 2007 May; 25(19):3879-89. PubMed ID: 17307281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and evaluation of an enzyme immunoassay for rapid diagnosis of rabies in humans and animals.
    Vasanth JP; Madhusudana SN; Abhilash KV; Suja MS; Muhamuda K
    Indian J Pathol Microbiol; 2004 Oct; 47(4):574-8. PubMed ID: 16295401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunogenicity and protective activity of glycoprotein extracted from rabies virus: results from comparison of preparations obtained by different methods of purification (author's transl)].
    Atanasiu P; Tsiang H; Perrin P; Favre S
    Ann Microbiol (Paris); 1976; 127B(2):257-67. PubMed ID: 999129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals.
    Lodmell DL; Esposito JJ; Ewalt LC
    Vaccine; 2004 Sep; 22(25-26):3329-33. PubMed ID: 15308356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of glycoprotein gene of the rabies virus 3aG strain by E-3 deleted adenovirus recombinant.
    Zhang X; Zhang Y; Li W
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Sep; 14(3):281-4. PubMed ID: 11498699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The rabies peripheral challenge test: more accurate determination of vaccine potency.
    Wunderli PS; Dreesen DW; Miller TJ; Baer GM
    Vaccine; 2006 Nov; 24(49-50):7115-23. PubMed ID: 16919854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification, potency and immunogenicity analysis of Vero cell culture-derived rabies vaccine: a comparative study of single-step column chromatography and zonal centrifuge purification.
    Prem Kumar AA; Mani KR; Palaniappan C; Bhau LN; Swaminathan K
    Microbes Infect; 2005 Jul; 7(9-10):1110-6. PubMed ID: 16046167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zonal centrifuge purification of human rabies vaccine obtained on bovine fetal kidney cells. Biological results.
    Atanasiu P; Tsiang H; Reculard P; Aguilon F; Lavergne M; Adamovicz P
    Dev Biol Stand; 1978; 40():35-44. PubMed ID: 680400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus.
    Xiang ZQ; Spitalnik S; Tran M; Wunner WH; Cheng J; Ertl HC
    Virology; 1994 Feb; 199(1):132-40. PubMed ID: 8116236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity of purified vero cell rabies vaccine used in the treatment of fox-bite victims in India.
    Matha IS; Salunke SR
    Clin Infect Dis; 2005 Feb; 40(4):611-3. PubMed ID: 15712086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.